James Dao

Biography

James Dao is a successful serial high tech inventor and co-founder based in Silicon Valley with over 35 years of experience in managing, inventing, developing, and commercializing advanced technologies and innovative applications. As founder and CEO of entrepreneurial companies, Mr. Dao is known for commercializing visionary business concepts and innovative products that have stimulated paradigm shifts in their industries. These companies (in instrumentation, semiconductors materials, design tools and manufacturing equipment, and mobile computing and cell phone software) reached public market capitalizations of US$2.7 billion and US$1.5 billion respectively. Mr. Dao’s technical accomplishments include developing next generation scanning electron beam microscopes that overcame previous limitations and allowed cancer research to progress since the 1970s. He also participated in the design of a pioneering machine that used radiation to treat cancer (now Varian’s medical instrument division). Mr. Dao and friends realized the need for molecular diagnostics combined with multivalent pharmaceuticals to fight cancer and other devastating chronic diseases. Mr. Dao co-founded Genyous Biomed International Inc. in 2000 to implement this vision of addressing cancer with a strategy based on systems biology that led to the creation of a drug development platform for non-toxic multivalent molecularly directed therapies. Omnitura Therapeutics Inc. is the second company to spin out from Genyous. James Dao is a successful serial high tech inventor and co-founder based in Silicon Valley with over 35 years of experience in managing, inventing, developing, and commercializing advanced technologies and innovative applications. As founder and CEO of entrepreneurial companies, Mr. Dao is known for commercializing visionary business concepts and innovative products that have stimulated paradigm shifts in their industries. These companies (in instrumentation, semiconductors materials, design tools and manufacturing equipment, and mobile computing and cell phone software) reached public market capitalizations of US$2.7 billion and US$1.5 billion respectively. Mr. Dao’s technical accomplishments include developing next generation scanning electron beam microscopes that overcame previous limitations and allowed cancer research to progress since the 1970s. He also participated in the design of a pioneering machine that used radiation to treat cancer (now Varian’s medical instrument division). Mr. Dao and friends realized the need for molecular diagnostics combined with multivalent pharmaceuticals to fight cancer and other devastating chronic diseases. Mr. Dao co-founded Genyous Biomed International Inc. in 2000 to implement this vision of addressing cancer with a strategy based on systems biology that led to the creation of a drug development platform for non-toxic multivalent molecularly directed therapies. Omnitura Therapeutics Inc. is the second company to spin out from Genyous.

Research Interest

development